Search Ontology:
ChEBI

beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-GlcpNAc

Term ID
CHEBI:147248
Synonyms
  • 2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->4)-beta-D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranose
  • 2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
  • GlcNAc(b1-4)Gal(b1-4)GlcNAc
  • N-[(3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-5-[(2S,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
Definition
An amino trisaccharide consisting of 2-acetamido-2-deoxy-β-D-glucopyranose, β-D-galactopyranose and 2-acetamido-2-deoxy-D-glucopyranose residues joine in sequence by (1→4) glycosidic bonds.
References
  • glygen:G07923CD
  • glytoucan:G07923CD
  • kegg.glycan:G08907
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-GlcpNAc
Phenotype where environments contain beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-GlcpNAc
Phenotype modified by environments containing beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-GlcpNAc
Phenotype affecting beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-GlcpNAc
Human Disease Model